Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jul;14(7):383-384.
doi: 10.1038/nrgastro.2017.57. Epub 2017 May 3.

Helicobacter pylori infection and antibiotic resistance: a WHO high priority?

Bich N Dang  1 , David Y Graham  2
Affiliations

Helicobacter pylori infection and antibiotic resistance: a WHO high priority?

Bich N Dang et al. Nat Rev Gastroenterol Hepatol. 2017 Jul.

Abstract

The WHO listed Helicobacter pylori among 16 antibiotic-resistant bacteria that pose the greatest threat to human health. Given the alarmingly high H. pylori antibiotic resistance rates, antibiotic stewardship programmes need to be developed and implemented. Future research should explore provider and systems-level barriers to H. pylori antibiotic susceptibility testing.

PubMed Disclaimer

Conflict of interest statement

Competing interests statement

D.Y.G. is a consultant for RedHill Biopharma regarding novel H. pylori therapies and has received research support for culture of H. pylori and is the principal investigator of an international study of the use of antimycobacterial therapy for Crohn’s disease. He is also a consultant for BioGaia in relation to probiotic therapy for H. pylori infection and for Takeda in relation to H. pylori therapies. B.N.D. declares no competing interests.

References

    1. Malfertheiner P et al. Management of Helicobacter pylori infection — the Maastricht V/Florence consensus report. Gut 66, 6–30 (2017). - PubMed
    1. Chey WD, Leontiadis GI, Howden CW & Moss SF ACG clinical guideline: treatment of Helicobacter pylori infection. Am. J. Gastroenterol. 112, 212–239 (2017). - PubMed
    1. Shiotani A, Lu H, Dore MP & Graham DY Treating Helicobacter pylori effectively while minimizing misuse of antibiotics. Cleve. Clin.J. Med 84, 310–318 (2017). - PMC - PubMed
    1. Graham DY & Dore MP Helicobacter pylori therapy: a paradigm shift. Expert. Rev. Anti Infect. Ther 14, 577–585 (2016). - PMC - PubMed
    1. Graham DY & Laine L The Toronto Helicobacter pylori consensus in context. Gastroenterology 151,9–12 (2016). - PMC - PubMed

Publication types

MeSH terms

Substances